Evidence map›Paper›PMID 31844045›Full record

ArticleNature communications2019

ATAD5 promotes replication restart by regulating RAD51 and PCNA in response to replication stress.

Su Hyung Park, Nalae Kang, Eunho Song, Minwoo Wie, Eun A Lee, Sunyoung Hwang, Deokjae Lee, Jae Sun Ra, In Bae Park, Jieun Park and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Heterogeneous CRISPR/Cas9 Editing ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Targeting IPNature communications · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Su Hyung ParkCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Nalae KangCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Eunho SongInterdisciplinary Graduate Program in Biophysics and Chemical Biology, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0000-0003-3245-1298
Minwoo WieDepartment of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Korea.
Eun A LeeCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Sunyoung HwangCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Deokjae LeeDepartment of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Korea.
Jae Sun RaCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
In Bae ParkCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Jieun ParkCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Sukhyun KangCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.
Jun Hong ParkCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea.ORCID http://orcid.org/0000-0001-8905-4125
Sungchul HohngInterdisciplinary Graduate Program in Biophysics and Chemical Biology, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0000-0002-7131-2138
Kyoo-Young LeeCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea. klee2910@ibs.re.kr.
Kyungjae MyungCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Korea. kmyung@ibs.re.kr.
Institute for Basic Science · KRSeoul National University · KRUlsan National Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining stability of replication forks is important for genomic integrity. However, it is not clear how replisome proteins contribute to fork stability under replication stress. Here, we report that ATAD5, a PCNA unloader, plays multiple functions at stalled forks including promoting its restart. ATAD5 depletion increases genomic instability upon hydroxyurea treatment in cultured cells and mice. ATAD5 recruits RAD51 to stalled forks in an ATR kinase-dependent manner by hydroxyurea-enhanced protein-protein interactions and timely removes PCNA from stalled forks for RAD51 recruitment. Consistent with the role of RAD51 in fork regression, ATAD5 depletion inhibits slowdown of fork progression and native 5-bromo-2'-deoxyuridine signal induced by hydroxyurea. Single-molecule FRET showed that PCNA itself acts as a mechanical barrier to fork regression. Consequently, DNA breaks required for fork restart are reduced by ATAD5 depletion. Collectively, our results suggest an important role of ATAD5 in maintaining genome integrity during replication stress.

Indexed as

ATPases Associated with Diverse Cellular ActivitiesBromodeoxyuridineCell Line, TumorDNA-Binding ProteinsDNA BreaksDNA RepairDNA ReplicationFlow CytometryFluorescence Resonance Energy TransferGene Knockdown TechniquesGenomic InstabilityHEK293 CellsHumansHydroxyureaProliferating Cell Nuclear AntigenProtein BindingATAD5 protein, humanATPases Associated with Diverse Cellular ActivitiesBromodeoxyuridineDNA-Binding ProteinsHydroxyureaPCNA protein, humanProliferating Cell Nuclear AntigenRAD51 protein, humanRad51 RecombinaseRNA, Small Interfering

Identifiers

PMID31844045
PMCPMC6914801
OpenAlexW2995737614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.